Abstract:The E3 ubiquitin ligase MDM2 functions as a crucial negative regulator of the p53 tumor suppressor protein by antagonizing p53 transactivation activity and targeting p53 for degradation. Cellular stress activates p53 by alleviating MDM2-mediated functional inhibition, even though the molecular mechanisms of stress-induced p53 activation still remain poorly understood. Two opposing models have been proposed to describe the functional and structural role in p53 activation of Ser17 phosphorylation in the N-terminal "lid" (residues 1-24) of MDM2. Using the native chemical ligation technique, we synthesized the p53-binding domain (1-109)MDM2 and its Ser17-phosphorylated analogue (1-109)MDM2 pS17 as well as (1-109)MDM2 S17D and (25-109)MDM2, and comparatively characterized their interactions with a panel of p53-derived peptide ligands using surface plasmon resonance, fluorescence polarization, and NMR and CD spectroscopic techniques. We found that the lid is partially structured in apo-MDM2 and occludes p53 peptide binding in a ligand size-dependent manner. Binding of (1-109)MDM2 by the (15-29)p53 peptide fully displaces the lid and renders it completely disordered in the peptide-protein complex. Importantly, neither Ser17 phosphorylation nor the phospho-mimetic mutation S17D has any functional impact on p53 peptide binding to MDM2. Although Ser17 phosphorylation or its mutation to Asp contributes marginally to the stability of the lid conformation in apo-MDM2, neither modification stabilizes apo-MDM2 globally or the displaced lid locally. Our findings demonstrate that Ser17 phosphorylation is functionally neutral with respect to p53 binding, suggesting that MDM2 phosphorylation at a single site is unlikely to play a dominant role in stress-induced p53 activation.

Phosphorylation-regulated HMGA1a-P53 interaction unveils the function of HMGA1a acidic tail phosphorylations via synthetic proteins

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Revealing the extracellular function of HMGB1 N-terminal region acetylation assisted by a protein semi-synthesis approach

Molecular Dynamics Simulation On Hp1 Protein Binding By Histone H3 Tail Methylation And Phosphorylation

Phosphorylation of the HMGN1 nucleosome binding domain decreases helicity and interactions with the acidic patch.

Chemical Synthesis of Post-Translationally Modified H2AX Reveals Redundancy in Interplay between Histone Phosphorylation, Ubiquitination, and Methylation on the Binding of 53BP1 with Nucleosomes

A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes.

Phosphorylation by Protein Kinase C Weakens DNA-Binding Affinity and Folding Stability of the HMGB1 Protein

SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Glutamylation of Npm2 and Nap1 acidic disordered regions increases DNA mimicry and histone chaperone efficiency

Modification of regulatory tyrosines biases human Hsp90α for interaction with cochaperones and clients

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2

Modification of regulatory tyrosine residues biases human Hsp90α in its interactions with cochaperones and clients

Site-Selective Phosphoglycerate Mutase 1 Acetylation by a Small Molecule

Real-time Surface Plasmon Resonance Monitoring of Site-Specific Phosphorylation of P53 Protein and Its Interaction with MDM2 Protein.

Interrogation of MDM2 Phosphorylation in P53 Activation Using Native Chemical Ligation: the Functional Role of Ser17 Phosphorylation in MDM2 Reexamined

Structural modulation of p53TAD1-TAZ2 complex upon mutations and post-translational modification

Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules

Molecular Basis for Bipartite Recognition of Histone H3 by the PZP Domain of PHF14.

High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential